Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial's eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 1 - 20 of 31 trials
Titlesort icon Investigator Disease(s)
Standard Infusion Carboplatin versus Prophylactic Extended Infusion Carboplatin in the Treatment of Patients with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
[Protocol 10-184]
O'Cearbhaill, Roisin
  • Ovarian Cancer
Phase I Study of Olaparib in Combination with Chemotherapy in Patients Newly Diagnosed with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 10-220]
Konner, Jason
  • Ovarian Cancer
Evaluation of an Assessment Tool to Predict Complications after Surgery in Elderly Women with Gynecologic Cancers
[Protocol 15-070]
Tew, William
  • Ovarian Cancer
  • Uterine (Endometrial) Cancer
Clinical Significance of Germline BRCA Mutations
[Protocol 96-051]
Offit, Kenneth
  • Breast Cancer
  • Colorectal Cancer
    • Colon Cancer
  • Hereditary Cancer & Genetics
  • Ovarian Cancer
  • Prostate Cancer
Biological, Behavioral, and Sociodemographic Characteristics of Long-Term Survivors of Ovarian Cancer
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-224]
Carter, Jeanne
  • Ovarian Cancer
  • Survivorship
A Study of an Online Support Group for Women Experiencing Sexual Distress due to a Gynecologic Cancer
[Protocol 14-245]
Carter, Jeanne
  • Cervical Cancer
  • Ovarian Cancer
  • Quality of Life
  • Survivorship
  • Uterine (Endometrial) Cancer
A Study Assessing Fluorestradiol PET/CT for Imaging Estrogen Receptor Status
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-071]
Ulaner, Gary
  • Breast Cancer
  • Cervical Cancer
  • Ovarian Cancer
A Pilot Study of Yoga Practice for Breast or Ovarian Cancer Survivors
[Protocol 14-059]
Deng, Gary
  • Breast Cancer
  • Ovarian Cancer
  • Survivorship
A Pilot Study Assessing PET Probes to Detect Cancerous Tissue During Surgery for Recurrent Ovarian Cancer
[Protocol 13-017]
Chi, Dennis
  • Ovarian Cancer
A Phase III Study of Rucaparib after Platinum-Based Chemotherapy in Women with High-Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 14-067]
Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase III Study of MEK162 versus Standard Chemotherapy in Patients with Recurrent or Persistent Low-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: The MILO Study
[Protocol 13-098]
Grisham, Rachel
  • Ovarian Cancer
A Phase III Study of Doxil Alone and with Yondelis (Trabectedin) in Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 13-153]
O'Cearbhaill, Roisin
  • Ovarian Cancer
A Phase II Study of Secondary Cytoreduction with and without HIPEC plus Postoperative Chemotherapy for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Relapsed/Refractory
[Protocol 12-275]
Chi, Dennis
  • Ovarian Cancer
A Phase II Study of Rucaparib in Patients Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Relapsed/Refractory
[Protocol 13-255]
Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase II Study of Paclitaxel/Carboplatin versus Bleomycin/Etoposide/Cisplatin for Patients with Advanced Ovarian Stromal Tumors Who Have Not Received Chemotherapy
Relapsed/Refractory
[Protocol 13-177]
Leitao, Mario
  • Ovarian Cancer
A Phase II Study of Neratinib in Patients with Solid Tumors Containing Mutated HER2
[Protocol 13-140]
Hyman, David
  • Bladder Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Solid Tumors
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
  • Uterine (Endometrial) Cancer
A Phase II Study of Enzalutamide in Patients with Advanced or Recurrent Androgen Receptor-Positive Ovarian Cancer
[Protocol 13-119]
Grisham, Rachel
  • Ovarian Cancer
A Phase II Study of Dasatinib to Treat Recurrent Clear Cell Cancer of the Ovaries or Endometrium
[Protocol 14-008]
Hyman, David
  • Ovarian Cancer
  • Uterine (Endometrial) Cancer
A Phase II Study of AZD1775 plus Chemotherapy Versus Chemotherapy Alone in Patients with TP53-Mutated Ovarian, Fallopian Tube, or Peritoneal Cancer
[Protocol 14-268]
Cadoo, Karen
  • Ovarian Cancer
A Phase Ib Study of OMP-54F28 with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
[Protocol 14-029]
O'Cearbhaill, Roisin
  • Ovarian Cancer